Metabolomics research reveals signs of autism.

, March 20, 2020 /PRNewswire/ --- In a paper published this week in the journal Autism Research, researchers at the University of California, Davis and others report new findings on childhood autismblood sample analysis from CAMP is the largest study to date on the metabolism of children with autism spectrum disorder (ASD), which analyzed the unique metabolic characteristics of more than 50 percent of children with autism, known as metabolic typesThis is an important step towards setting the goal of establishing a set of metabolomic tests that could lay the foundation for biological screening of the risks of ASD"Using a metabolomic method to detect objective biomarkers of ASD is a promising approach because the interaction between metabolites to the genome, gastrointestinal microbiome, diet and all environmental factors increases the risk of autism," said DrRobert Burrier, chief operating officer of Stemina,author of the(picture:The "
" CAMP study is a pioneering study of the metabolism of autistic childrenThe study was carefully designed to identify and verify typical metabolic differences between children with ASD and normal child populations," said the authors of the study, drElizabeth DonleyDrAmaral said: "There are currently no effective biomarkers to detect autism risk in young children, and we are optimistic about this approach, which has the potential to detect the risk of childhood disease as early as possibleIn addition, this approach provides new targeted and personalized therapiesThese questions need to be further tested in CAMP studiesDonley added: "The new findings from the CAMP study represent advances in our efforts to develop metabolomics-based ASD screening tools, and while there are no signs of definitive diagnosis of ASD, combining metabolomics-based screening with behavioral testing can increase the likelihood of early detection of people at risk of ASD." " (Bio Valley Bioon.com)source: A metabolomics approach to detect objective biomarkers of ASD original origin: a metabolomics for screening for autism risk in the children's autismemememe.project.
Autism Research, 2020: doi: 10.1002/aur.2330
.